Go to deals
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady and based in Nijmegen, the Netherlands, ScreenPoint Medical develops and markets innovative machine learning solutions to improve breast cancer screening and diagnosis. With its market-leading AI solution Transpara, ScreenPoint Medical supports radiologists in evaluating mammograms to detect breast cancer and allows them to improve the quality and efficiency of breast cancer screening. Transpara is currently used in over 200 clinics in 25 countries worldwide.

Insight Partners is a US-based venture capital and private equity firm with more than US$30 billion in capital commitments. With its experience and track record of investing in high-growth technology and software companies that drive transformative change in their industries, Insight Partners is ideally situated to support ScreenPoint Medical with its endeavors. Alongside Insight Partners, University Radiology Group, one of the largest providers of sub-specialty radiology and teleradiology services in the United States, participated in the investment round. Existing investors, including ScreenPoint Medical’s founders Siemens Healthineers and Oost NL, will continue to support the company in its further growth and development.

Oaklins’ team in the Netherlands acted as the exclusive advisor to the shareholders and management of ScreenPoint Medical.

About ScreenPoint

ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, the Netherlands, to develop and bring to market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis and breast imaging, ScreenPoint developed the market-leading AI solution Transpara for reading mammograms and breast tomosynthesis.

About Insight Partners

Insight Partners is a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than US$30 billion in capital commitments. Insight's mission is to find, fund and work successfully with visionary executives, providing them with practical, hands-on software expertise to foster long-term success. Across its people and its portfolio, Insight encourages a culture around a belief that ScaleUp companies and growth create opportunity for all.

“We are delighted to welcome Insight Partners as a new shareholder of ScreenPoint Medical. Their broad experience and network within the medical technology sector will enable us to further develop and commercialize our AI solution. The support and guidance of the Oaklins team, together with their experience in the medical imaging space, has proven extremely valuable throughout this process.”

Nico Karssemeijer

Founder and CEO

Talk to the deal team

 Robert  Boersma

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands
 Martijn  de Win

Martijn de Win

Director
Amsterdam, Netherlands
Oaklins Netherlands
 Robbert  Bon

Robbert Bon

Senior Associate
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Perkbox has been acquired by Great Hill Partners
Private Equity | TMT

Perkbox has been acquired by Great Hill Partners

Molten Ventures has sold Perkbox to Great Hill Partners.

Learn more
Arculus Cyber Security has been acquired by Bridewell
Private Equity | TMT

Arculus Cyber Security has been acquired by Bridewell

The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.

Learn more
PCI Pal has completed an equity raise
Financial Services | TMT

PCI Pal has completed an equity raise

PCI Pal has completed a fundraising. Funds will be allocated towards several key areas, with a significant portion directed towards supporting its continued expansion in the US, focusing on marketing efforts, product marketing and enhancing engagement with key partners.

Learn more